UAB “Imunodiagnostika” investments in R & D: innovation in Allergies Diagnostics (Q3778188): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: import item from Lithuania) |
(Changed an Item: Adding English translations) |
||||||||||||||
| Property / summary | |||||||||||||||
UAB “Imunodiagnostika” was established in 2013 in order to realise long-term experience in the diagnosis of allergic diseases and to develop innovative diagnostic products. Company 2015 completed the implementation of the project, during which a modern laboratory was installed and equipment needed for the development of diagnostic kits for allergic diseases, based on innovative micro-gardel technology. The main strategic direction of the laboratory today is focused on innovative solutions for the diagnosis of allergic diseases. Long-term objectives of the company: • To become a competitive company in Lithuania and abroad, supplying the market with innovative products for the diagnosis and research of allergic diseases; • Carry out research work necessary for the development of biotechnological products; • Outsourced commercial diagnostic tests; • Continuous improvement of the company’s performance focused on the needs of the user. With this project UAB “Imunodiagnostika” aims to develop prototypes of two diagnostic kits based on innovative micro-garde technology: • Type I hypersensitivity to medications • For type I-o hypersensitivity, inhaled and domestic allergens; It is planned to develop a number of innovative biotechnological commercial value products, such as recombinant proteins/allergens and monoclonal antibodies. (English) | |||||||||||||||
| Property / summary: UAB “Imunodiagnostika” was established in 2013 in order to realise long-term experience in the diagnosis of allergic diseases and to develop innovative diagnostic products. Company 2015 completed the implementation of the project, during which a modern laboratory was installed and equipment needed for the development of diagnostic kits for allergic diseases, based on innovative micro-gardel technology. The main strategic direction of the laboratory today is focused on innovative solutions for the diagnosis of allergic diseases. Long-term objectives of the company: • To become a competitive company in Lithuania and abroad, supplying the market with innovative products for the diagnosis and research of allergic diseases; • Carry out research work necessary for the development of biotechnological products; • Outsourced commercial diagnostic tests; • Continuous improvement of the company’s performance focused on the needs of the user. With this project UAB “Imunodiagnostika” aims to develop prototypes of two diagnostic kits based on innovative micro-garde technology: • Type I hypersensitivity to medications • For type I-o hypersensitivity, inhaled and domestic allergens; It is planned to develop a number of innovative biotechnological commercial value products, such as recombinant proteins/allergens and monoclonal antibodies. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: UAB “Imunodiagnostika” was established in 2013 in order to realise long-term experience in the diagnosis of allergic diseases and to develop innovative diagnostic products. Company 2015 completed the implementation of the project, during which a modern laboratory was installed and equipment needed for the development of diagnostic kits for allergic diseases, based on innovative micro-gardel technology. The main strategic direction of the laboratory today is focused on innovative solutions for the diagnosis of allergic diseases. Long-term objectives of the company: • To become a competitive company in Lithuania and abroad, supplying the market with innovative products for the diagnosis and research of allergic diseases; • Carry out research work necessary for the development of biotechnological products; • Outsourced commercial diagnostic tests; • Continuous improvement of the company’s performance focused on the needs of the user. With this project UAB “Imunodiagnostika” aims to develop prototypes of two diagnostic kits based on innovative micro-garde technology: • Type I hypersensitivity to medications • For type I-o hypersensitivity, inhaled and domestic allergens; It is planned to develop a number of innovative biotechnological commercial value products, such as recombinant proteins/allergens and monoclonal antibodies. (English) / qualifier | |||||||||||||||
point in time: 1 February 2022
| |||||||||||||||
Revision as of 09:01, 1 February 2022
Project Q3778188 in Lithuania
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | UAB “Imunodiagnostika” investments in R & D: innovation in Allergies Diagnostics |
Project Q3778188 in Lithuania |
Statements
741,627.86 Euro
0 references
1,338,082.85 Euro
0 references
55.42 percent
0 references
1 March 2017
0 references
28 February 2021
0 references
UAB "Imunodiagnostika"
0 references
14260
0 references
UAB “Imunodiagnostika” įkurta 2013 m., siekiant realizuoti ilgalaikę patirtį alerginių ligų diagnostikoje ir kurti inovatyvius diagnostikos produktus. Įmonė 2015 baigė įgyvendinti projektą, kurio metu buvo įrengta moderni laboratorija ir įsigyta įranga, reikalinga alerginių ligų diagnostikai skirtų rinkinių, paremų inovatyvia mikrogardelių technologija, kūrimui. Pagrindinė šiandieninė laboratorijos strateginė kryptis yra orientuota į alerginių ligų diagnostikos inovatyvius sprendimus. Ilgalaikiai įmonės tikslai: • Tapti konkurencinga įmone Lietuvoje ir užsienyje, tiekiančia rinkai inovatyvius gaminius, skirtus alerginių ligų diagnostikai ir moksliniams tyrimams.; • Vykdyti mokslinius tiriamuosius darbus, reikalingus biotechnologinių produktų kūrimui; • Atlikti užsakomuosius komercinius diagnostinius tyrimus; • Nuolatinis įmonės veiklos gerinimas orientuojantis į vartotojo poreikius. Šiuo projektu UAB “Imunodiagnostika” siekia sukurti dviejų diagnostinių rinkinių, paremtų inovatyvia mikrogardelių technologija, prototipus: • I-o tipo hiperjautrumui medikamentams nustatyti; • I-o tipo hiperjautrumui, įkvepiamiems ir buitiniams alergenams nustatyti; Mikrogardelių kūrimo procese planuojama sukurti keletą šalies mastu inovatyvių biotechnologinę komercinę vertę turinčių produktų – rekombinantinių baltymų/alergenų bei monokloninių antikūnų. (Lithuanian)
0 references
UAB “Imunodiagnostika” was established in 2013 in order to realise long-term experience in the diagnosis of allergic diseases and to develop innovative diagnostic products. Company 2015 completed the implementation of the project, during which a modern laboratory was installed and equipment needed for the development of diagnostic kits for allergic diseases, based on innovative micro-gardel technology. The main strategic direction of the laboratory today is focused on innovative solutions for the diagnosis of allergic diseases. Long-term objectives of the company: • To become a competitive company in Lithuania and abroad, supplying the market with innovative products for the diagnosis and research of allergic diseases; • Carry out research work necessary for the development of biotechnological products; • Outsourced commercial diagnostic tests; • Continuous improvement of the company’s performance focused on the needs of the user. With this project UAB “Imunodiagnostika” aims to develop prototypes of two diagnostic kits based on innovative micro-garde technology: • Type I hypersensitivity to medications • For type I-o hypersensitivity, inhaled and domestic allergens; It is planned to develop a number of innovative biotechnological commercial value products, such as recombinant proteins/allergens and monoclonal antibodies. (English)
1 February 2022
0 references
Molėtų 16, Didžiosios Riešės k., Vilniaus r.
0 references
Identifiers
J05-LVPA-K-01-0155
0 references